Abstract:The outbreaks of type O foot-and-mouth disease(FMD) severely affect development of Chinese hog industry,its causative agent is type O foot-and-mouth disease virus(FMDV),which has been evolved several lineages.The available FMD vaccines in China cannot afford sufficient protection against viruses of multi-lineages,which exert important obstacle to disease control.In order to develop vaccine candidate with characteristics of good immunogenicity and broad spectrotype,we constructed a full-length cDNA clone with genetically modified in capsid protein VP3(58 amino acid) and VP1(43,48,137,139,140,141,142 amino acid) based on the infectious cDNA clone of O/HN/93 vaccine strain.Upon cotransfection of BHK-21 cells with linearized recombinant plasmids and plasmids expressing T7 RNA polymerase,the virus was rescued.The results of RT-PCR and sulk mice pathogenicity showed that the rescued virus could be stably maintained during serial passages and has similar pathogenicity with parental virus for sulk mice.To test if the genetically modified virus can be used as a vaccine candidate,the pigs inoculated with inactivated FMD vaccine which made from rV-OSyNa and O/HN/93 viruses were challenged with swine-isolated strains of Chathay,PanAsia and Mya98 topotypes,respectively.As a result,the rV-OSyNa vaccinated pigs were fully protected against three viruses challenge after 28 days post-vaccination,in contrast,16/16 O/HN/93 vaccinated animals fully protected against viruses of PanAsia and Mya98 topotypes challenge,but only 12 /16 O/HN/93 vaccinated animals got protection from virus of Chathay challenge.Our results demonstrated that genetically engineered FMDV is a good vaccine candidate with improving protection against virus of Chathay topotype challenge and expanding spectrotype.

Tandem Expression and Activity Analysis of Antigen Peptide of Swine Foot and Mouth Disease (type O) Synthetic Peptide Vaccine

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

Construction of Genetically Engineered Vaccine Candidate of Type O Foot-and-Mouth-Disease Virus of Pig and Analysis of Its Immunogenicity

Construction of Recombinant Adenovirus Co-expressing VP1-2A of Foot and Mouth Disease Virus and Porcine IL-2 and Its Immune Effects

Prokaryotic expression and purification of multiple antigen epitopes of swine foot-and-mouth disease virus

Prokaryotic Expression and Activity Analysis of VP1 Gene of Foot-and-Mouth Disease Virus Serotype O

Construction, Expression and Purification of the Recombinant VP1 Epitope Vaccine for Foot and Mouth Disease Virus Bovine O Type and Investigation on Its Immunological Activity

Fusion Expression of Immunological Epitopes from VP1-3 of Foot-and-mouth Disease Virus with Porcine Interferon-Gamma

[Fusion Expression of O Type Foot-and-mouth Diseases Virus VP1 Gene and HSP70 Gene and Induction of Immune Responses in Mice].

Development of a Synthetic Peptide ELISA Assay for the Detection of Foot-and-Mouth Disease Virus Nonstructural Protein Antibodies

Recombinant Expression and Activity Identification of 3D Protein C Terminal Th Epitope Peptides of Foot and Mouth Disease Virus

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Expression and immunogenicity of recombinant fusion protein comprising foot-and-mouth disease virus structural protein VP1 and intercellular adhesion molecule ICAM-2

Expression of the Major Epitope Regions of 2C Integrated with the 3AB Non-Structural Protein of Foot-and-mouth Disease Virus and Its Potential for Differentiating Infected from Vaccinated Animals

Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep

Antibody Level Monitoring of Swine Foot and Mouth Disease Virus Serotype O Based on Immunochromatographic Strip

Development of an ELISA for Detection of Foot-and-Mouth Nonstructural Protein Antibody with Synthetic Peptides

Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine.

Expression,Purification and Identification of 3D Protein N Terminal T Cell Epitope Recombinant Protein of Foot and Mouth Disease Virus

Recombinant Bivalent Vaccine Against Foot-and-Mouth Disease Virus Serotype O/A Infection in Guinea Pig